Prasco to market generic Furadantin Oral Suspension
Prasco plans to start shipping Nitrofurantoin Oral Suspension immediately in the US under the Prasco label. Nitrofurantoin is used to treat urinary tract infections. Prasco CEO Thomas Arington
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.